ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, vol.19, no.9, pp.1184-1195, 2019 (SCI-Expanded)
Background: Prostate cancer is one of the most common cancer types and it is the sixth leading cause of cancer-related death in men worldwide. Even though novel treatment modalities have been developed, it still a lifethreatening disease. Therefore novel compounds are needed to improve the overall survival.